Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Alkermes (8AK) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:8AKAlkermesEUR 43.52EUR 7.27B15935.0051.11%Moderate BuyUnlock the DE:8AK analyst price target with TipRanks PremiumDE:8AKUnlock the DE:8AK top-analyst price target with TipRanks Premium
RDYDr Reddy's Laboratories$14.73$12.20B41.276.35%Moderate BuyUnlock the RDY analyst price target with TipRanks PremiumDE:8AK vs RDYUnlock the RDY top-analyst price target with TipRanks Premium
VTRSViatris$20.67$24.14B-39.4287.74%Moderate BuyUnlock the VTRS analyst price target with TipRanks PremiumDE:8AK vs VTRSUnlock the VTRS top-analyst price target with TipRanks Premium
SUPNSupernus$29.20$6.12B8.09-2.99%Strong BuyUnlock the SUPN analyst price target with TipRanks PremiumDE:8AK vs SUPNUnlock the SUPN top-analyst price target with TipRanks Premium
TAKTakeda Pharmaceutical Company$21.12$66.62B27.8749.89%Moderate BuyUnlock the TAK analyst price target with TipRanks PremiumDE:8AK vs TAKUnlock the TAK top-analyst price target with TipRanks Premium

Performance Comparison

-25%0%25%50%75%100%125%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:8AKAlkermes43.5217.1264.85%
RDYDr Reddy's Laboratories14.730.876.25%
VTRSViatris20.6710.3299.67%
SUPNSupernus29.205.5423.43%
TAKTakeda Pharmaceutical Company21.126.8347.80%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts